Fisher Asset Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-59,771	Closed	-$316K	–	976
2021 Q2	$316K	Buy	59,771 +22,279	+59%	+$115K	﹤0.01%	795
2021 Q1	$180K	Buy	37,492 +1,342	+4%	+$7.01K	﹤0.01%	868
2020 Q4	$157K	Sell	36,150 -22,840	-39%	-$97.7K	﹤0.01%	885
2020 Q3	$243K	Buy	58,990 +27	+0%	+$104	﹤0.01%	779
2020 Q2	$151K	Hold	58,963	–	–	﹤0.01%	787
2020 Q1	$170K	Hold	58,963	–	–	﹤0.01%	737
2019 Q4	$223K	Sell	58,963 -79,761	-57%	-$382K	﹤0.01%	776
2019 Q3	$710K	Hold	138,724	–	–	﹤0.01%	642
2019 Q2	$860K	Buy	138,724 +22,705	+20%	+$131K	﹤0.01%	613
2019 Q1	$825K	Sell	116,019 -5,440	-4%	-$48.9K	﹤0.01%	597
2018 Q4	$1.04M	Buy	121,459 +3,342	+3%	+$43.5K	﹤0.01%	596
2018 Q3	$2.37M	Sell	118,117 -28,012	-19%	-$658K	﹤0.01%	508
2018 Q2	$3.77M	Buy	146,129 +109,698	+301%	+$3.04M	﹤0.01%	467
2018 Q1	$871K	Hold	36,431	–	–	﹤0.01%	579
2017 Q4	$1.24M	Sell	36,431 -75	-0.2%	-$2.09K	﹤0.01%	564
2017 Q3	$773K	Buy	+36,506	New	+$669K	﹤0.01%	585